Showing results (31-40 of 44) with videos related to
Sort By:
Pageof 5
Pharmaceuticals (Basel, Switzerland)|September 23, 2022
Synthesis and Structure-Activity Relationships for the Anti-Mycobacterial Activity of 3-Phenyl-<i>N</i>-(Pyridin-2-ylmethyl)Pyrazolo[1,5-<i>a</i>]Pyrimidin-7-AminesHamish S Sutherland, Peter J Choi, Guo-Liang Lu, et al.Gland Surgery|January 15, 2021
Beforehand transection and suturing (BTS) of the dorsal vascular complex: a novel technique in laparoscopic radical prostatectomyJun-Wei Pan, Xing-Wei Jin, Fang-Xiu Luo, et al.BMC Surgery|March 7, 2021
Needle Adjustment Free (NAF) running suture technique (PAN suture) in laparoscopic partial nephrectomyJun-Wei Pan, Xiang Zhang, Xing-Wei Jin, et al.Bioorganic & Medicinal Chemistry|October 2, 2020
Synthesis and structure-activity relationships for tetrahydroisoquinoline-based inhibitors of Mycobacterium tuberculosisGuo-Liang Lu, Amy S T Tong, Daniel Conole, et al.Inorganic Chemistry|June 19, 2013
Cross-bridged cyclen or cyclam Co(III) complexes containing cytotoxic ligands as hypoxia-activated prodrugsJohn Yu-Chih Chang, Guo-Liang Lu, Ralph J Stevenson, et al.European Journal of Medicinal Chemistry|December 28, 2021
Synthesis and structure-activity relationships for a new class of tetrahydronaphthalene amide inhibitors of Mycobacterium tuberculosisHamish S Sutherland, Guo-Liang Lu, Amy S T Tong, et al.Bioorganic Chemistry|June 12, 2026
A homologous cell membrane-coated peptide-based USP7 degrader enhances degradation efficiency and anti-tumor activity in gastric CancerCong-Cong Ma, Cheng-Yun Jin, Nin-Jie Guo, et al.Journal of Medicinal Chemistry|October 29, 2025
Identification of Novel Phenoxazine-Derived LSD1 Inhibitors Suppressing Gastric Cancer Stemness by β-Catenin Transcriptional RegulationXing-Jie Dai, Leipeng Xue, Ying Liu, et al.Medicinal Research Reviews|May 8, 2026
Histone Deacetylase Meets Protein Degradation: Accelerating Anticancer Drug DiscoveryJun-Jie Wang, Ya Gao, Xin-Qian Ji, et al.Theranostics|May 7, 2026
Small molecules targeting the PD-1/PD-L1 axis for cancer immunotherapyJia-Yi Yin, Hui-Min Liu, Shao-Long Li, et al.Pageof 5